QIAstat-Dx Meningitis/Encephalitis Panel

The QIAstat-Dx Meningitis/Encephalitis Panel is a multiplex syndromic test designed for rapid, comprehensive analysis of central nervous system infections. It delivers simultaneous detection of multiple bacterial, viral, and fungal pathogens from a single cerebrospinal fluid sample.

Rapid, syndromic testing for central nervous system infections

This panel is optimized for the differential diagnosis of meningitis and encephalitis, helping clinicians quickly distinguish between infectious causes. By consolidating multiple individual tests into one streamlined assay, it supports faster, more informed treatment decisions and improved patient management.

Streamlined workflow and integrated analysis

The QIAstat-Dx Meningitis/Encephalitis Panel is designed for use on a fully integrated platform that combines sample preparation, nucleic acid amplification, and detection in a single cartridge. Minimal hands-on time and an intuitive interface reduce operator variability and support consistent, reproducible results in routine and urgent settings.

Comprehensive pathogen coverage in a single panel

The panel targets a broad range of clinically relevant pathogens associated with meningitis and encephalitis, enabling comprehensive coverage from one test run. This syndromic approach reduces the need for multiple separate assays and supports efficient use of laboratory resources.

Key features and benefits of QIAstat-Dx Meningitis/Encephalitis Panel:

• Multiplex syndromic panel for meningitis and encephalitis pathogen detection
• Single cerebrospinal fluid sample for broad bacterial, viral, and fungal coverage
• Integrated cartridge-based workflow with minimal hands-on time
• Rapid turnaround to support timely clinical decision-making
• Standardized, automated processing for consistent, reproducible results